{"transactions":[{"id":673329,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2026-08-28T17:00:01.000Z","date":"2026-08-26","kind":"other","planned":false,"acquired":false,"shares":7769,"price":429,"value":3332901.0,"ownership":{"direct":false,"nature":"By 2026 GRAT"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026,  the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-374693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526374693/ownership.xml","form_type":"4"}},{"id":785679,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-05-11T17:27:42.000Z","date":"2026-05-07","kind":"gift","planned":false,"acquired":true,"shares":3336,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By MAM 2020 Trust"},"balance_after":46576,"source":{"system":"sec-edgar","filing":"0001193125-26-217167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526217167/ownership.xml","form_type":"4"}},{"id":785678,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-05-11T17:27:42.000Z","date":"2026-05-07","kind":"gift","planned":false,"acquired":false,"shares":3336,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-217167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526217167/ownership.xml","form_type":"4"}},{"id":797431,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":50706,"kind":"person","name":"Frist William R","position":1,"cik":"0001433377","reported_name":"Frist William R","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-04-30T19:13:20.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\") underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested Shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer."}],"balance_after":13740,"source":{"system":"sec-edgar","filing":"0001140361-26-018355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126018355/form4.xml","form_type":"4"}},{"id":797430,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":50705,"kind":"person","name":"FRIST THOMAS F III","position":1,"cik":"0001223892","reported_name":"FRIST THOMAS F III","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-04-30T19:06:13.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":1041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\") underlying 509 restricted share units attributable to an annual director equity award and 532 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested Shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer."}],"balance_after":15858,"source":{"system":"sec-edgar","filing":"0001140361-26-018352","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126018352/form4.xml","form_type":"4"}},{"id":797429,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":11669,"kind":"person","name":"Smith Andrea B","position":1,"cik":"0001649634","reported_name":"Smith Andrea B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T17:06:23.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer."}],"balance_after":4666,"source":{"system":"sec-edgar","filing":"0001193125-26-197781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197781/ownership.xml","form_type":"4"}},{"id":797428,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":16387,"kind":"person","name":"Riley Wayne Joseph","position":1,"cik":"0001432895","reported_name":"Riley Wayne Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T17:04:10.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer."}],"balance_after":15029,"source":{"system":"sec-edgar","filing":"0001193125-26-197773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197773/ownership.xml","form_type":"4"}},{"id":797427,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":17046,"kind":"person","name":"MICHELSON MICHAEL W","position":1,"cik":"0001182415","reported_name":"MICHELSON MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T17:02:00.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 416 restricted share units received in lieu of annual cash retainers for service as a director and as independent presiding director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc."}],"balance_after":12576,"source":{"system":"sec-edgar","filing":"0001193125-26-197763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197763/ownership.xml","form_type":"4"}},{"id":797425,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":10681,"kind":"person","name":"Johnston Hugh F","position":1,"cik":"0001377489","reported_name":"Johnston Hugh F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T17:00:38.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc."}],"balance_after":4475,"source":{"system":"sec-edgar","filing":"0001193125-26-197757","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197757/ownership.xml","form_type":"4"}},{"id":797426,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":15170,"kind":"person","name":"DEPARLE NANCY ANN","position":1,"cik":"0001144511","reported_name":"DEPARLE NANCY ANN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T16:59:04.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date."}],"balance_after":21910,"source":{"system":"sec-edgar","filing":"0001193125-26-197746","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197746/ownership.xml","form_type":"4"}},{"id":797424,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T16:57:26.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date."}],"balance_after":1305,"source":{"system":"sec-edgar","filing":"0001193125-26-197734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526197734/ownership.xml","form_type":"4"}},{"id":898822,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Stock Appreciation Right","published_at":"2026-02-18T19:18:28.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023."}],"balance_after":8860,"derivative":{"exercise_price":236.61,"expiration_date":"2032-01-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-057701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526057701/ownership.xml","form_type":"4"}},{"id":898821,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2026-02-18T19:18:28.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":1694,"price":533.3747,"value":903536.7418,"ownership":{"direct":true},"balance_after":8853,"source":{"system":"sec-edgar","filing":"0001193125-26-057701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526057701/ownership.xml","form_type":"4"}},{"id":898820,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2026-02-18T19:18:28.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":3306,"price":540.29,"value":1786198.74,"ownership":{"direct":true},"balance_after":10547,"source":{"system":"sec-edgar","filing":"0001193125-26-057701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526057701/ownership.xml","form_type":"4"}},{"id":898819,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2026-02-18T19:18:28.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":236.61,"value":1183050.0,"ownership":{"direct":true},"balance_after":13853,"source":{"system":"sec-edgar","filing":"0001193125-26-057701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526057701/ownership.xml","form_type":"4"}},{"id":908652,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66801,"kind":"person","name":"Wyatt Christopher F.","position":1,"cik":"0001673365","reported_name":"Wyatt Christopher F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2026-02-12T18:55:42.000Z","date":"2026-02-11","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":505,"value":2020000.0,"ownership":{"direct":true},"balance_after":44379,"source":{"system":"sec-edgar","filing":"0001193125-26-049224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049224/ownership.xml","form_type":"4"}},{"id":908651,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66801,"kind":"person","name":"Wyatt Christopher F.","position":1,"cik":"0001673365","reported_name":"Wyatt Christopher F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2026-02-12T18:55:42.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1034,"price":502.05,"value":519119.7,"ownership":{"direct":true},"balance_after":48379,"source":{"system":"sec-edgar","filing":"0001193125-26-049224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049224/ownership.xml","form_type":"4"}},{"id":908650,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66801,"kind":"person","name":"Wyatt Christopher F.","position":1,"cik":"0001673365","reported_name":"Wyatt Christopher F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2026-02-12T18:55:42.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":3350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 1,675 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":49413,"source":{"system":"sec-edgar","filing":"0001193125-26-049224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049224/ownership.xml","form_type":"4"}},{"id":908649,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66800,"kind":"person","name":"Rossitto Erica","position":1,"cik":"0002108748","reported_name":"Rossitto Erica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Nurse Executive"}}],"security":"Common Stock","published_at":"2026-02-12T18:53:14.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":418,"price":502.05,"value":209856.9,"ownership":{"direct":true},"balance_after":10407,"source":{"system":"sec-edgar","filing":"0001193125-26-049221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049221/ownership.xml","form_type":"4"}},{"id":908648,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66800,"kind":"person","name":"Rossitto Erica","position":1,"cik":"0002108748","reported_name":"Rossitto Erica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Nurse Executive"}}],"security":"Common Stock","published_at":"2026-02-12T18:53:14.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":1676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 838 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":10825,"source":{"system":"sec-edgar","filing":"0001193125-26-049221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049221/ownership.xml","form_type":"4"}},{"id":908647,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2026-02-12T18:51:40.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3006,"price":502.05,"value":1509162.3,"ownership":{"direct":true},"balance_after":8853,"source":{"system":"sec-edgar","filing":"0001193125-26-049217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049217/ownership.xml","form_type":"4"}},{"id":908646,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2026-02-12T18:51:40.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":8372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 4,186 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":11859,"source":{"system":"sec-edgar","filing":"0001193125-26-049217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049217/ownership.xml","form_type":"4"}},{"id":908645,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-12T18:48:37.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1690,"price":502.05,"value":848464.5,"ownership":{"direct":true},"balance_after":3336,"source":{"system":"sec-edgar","filing":"0001193125-26-049208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049208/ownership.xml","form_type":"4"}},{"id":908644,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-12T18:48:37.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":5026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 2,513 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":5026,"source":{"system":"sec-edgar","filing":"0001193125-26-049208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049208/ownership.xml","form_type":"4"}},{"id":908636,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-12T18:45:03.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":21323,"price":502.05,"value":10705212.15,"ownership":{"direct":true},"balance_after":64842,"source":{"system":"sec-edgar","filing":"0001193125-26-049200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049200/ownership.xml","form_type":"4"}},{"id":908635,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-12T18:45:03.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":54934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":86165,"source":{"system":"sec-edgar","filing":"0001193125-26-049200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049200/ownership.xml","form_type":"4"}},{"id":908643,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2026-02-12T18:43:23.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5888,"price":502.05,"value":2956070.4,"ownership":{"direct":true},"balance_after":23062,"source":{"system":"sec-edgar","filing":"0001193125-26-049197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049197/ownership.xml","form_type":"4"}},{"id":908642,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2026-02-12T18:43:23.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":15696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 7,848 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":28950,"source":{"system":"sec-edgar","filing":"0001193125-26-049197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049197/ownership.xml","form_type":"4"}},{"id":908634,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2026-02-12T18:38:22.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3501,"price":502.05,"value":1757677.05,"ownership":{"direct":true},"balance_after":32079.9017,"source":{"system":"sec-edgar","filing":"0001193125-26-049186","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049186/ownership.xml","form_type":"4"}},{"id":908633,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2026-02-12T18:38:22.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":9628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 4,814 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":35580.9017,"source":{"system":"sec-edgar","filing":"0001193125-26-049186","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049186/ownership.xml","form_type":"4"}},{"id":908640,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66798,"kind":"person","name":"Berres Jennifer","position":1,"cik":"0001793262","reported_name":"Berres Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Human Res. Officer"}}],"security":"Common Stock","published_at":"2026-02-12T18:36:34.000Z","date":"2026-02-11","kind":"sale","planned":false,"acquired":false,"shares":4010,"price":526.1646,"value":2109920.046,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.97to $526.3101, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11993,"source":{"system":"sec-edgar","filing":"0001193125-26-049184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049184/ownership.xml","form_type":"4"}},{"id":908639,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66798,"kind":"person","name":"Berres Jennifer","position":1,"cik":"0001793262","reported_name":"Berres Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Human Res. Officer"}}],"security":"Common Stock","published_at":"2026-02-12T18:36:34.000Z","date":"2026-02-11","kind":"sale","planned":false,"acquired":false,"shares":4010,"price":503,"value":2017030.0,"ownership":{"direct":true},"balance_after":16003,"source":{"system":"sec-edgar","filing":"0001193125-26-049184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049184/ownership.xml","form_type":"4"}},{"id":908638,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66798,"kind":"person","name":"Berres Jennifer","position":1,"cik":"0001793262","reported_name":"Berres Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Human Res. Officer"}}],"security":"Common Stock","published_at":"2026-02-12T18:36:34.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2515,"price":502.05,"value":1262655.75,"ownership":{"direct":true},"balance_after":20013,"source":{"system":"sec-edgar","filing":"0001193125-26-049184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049184/ownership.xml","form_type":"4"}},{"id":908637,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66798,"kind":"person","name":"Berres Jennifer","position":1,"cik":"0001793262","reported_name":"Berres Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Human Res. Officer"}}],"security":"Common Stock","published_at":"2026-02-12T18:36:34.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":7116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 30, 2023, the reporting person was granted 3,558 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted."}],"balance_after":22528,"source":{"system":"sec-edgar","filing":"0001193125-26-049184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526049184/ownership.xml","form_type":"4"}},{"id":913226,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":67114,"kind":"person","name":"FRIST THOMAS F JR","position":1,"cik":"0000900596","reported_name":"FRIST THOMAS F JR","relationship":{"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:32.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":true,"shares":36557141,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of the Reporting Person. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of 846,050 Shares by the Reporting Person."}],"balance_after":36557141,"source":{"system":"sec-edgar","filing":"0001140361-26-004686","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004686/form4.xml","form_type":"4"}},{"id":913225,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":67114,"kind":"person","name":"FRIST THOMAS F JR","position":1,"cik":"0000900596","reported_name":"FRIST THOMAS F JR","relationship":{"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:32.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":false,"shares":36629188,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-004686","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004686/form4.xml","form_type":"4"}},{"id":913224,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":50706,"kind":"person","name":"Frist William R","position":1,"cik":"0001433377","reported_name":"Frist William R","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:31.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":true,"shares":36557141,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 3,156,495 Shares by the Reporting Person; and 8,713,110 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee."}],"balance_after":36557141,"source":{"system":"sec-edgar","filing":"0001140361-26-004685","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004685/form4.xml","form_type":"4"}},{"id":913223,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":50706,"kind":"person","name":"Frist William R","position":1,"cik":"0001433377","reported_name":"Frist William R","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:31.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":false,"shares":36629188,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-004685","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004685/form4.xml","form_type":"4"}},{"id":913222,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":50705,"kind":"person","name":"FRIST THOMAS F III","position":1,"cik":"0001223892","reported_name":"FRIST THOMAS F III","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:29.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":true,"shares":36557141,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,868,140 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee."}],"balance_after":36557141,"source":{"system":"sec-edgar","filing":"0001140361-26-004684","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004684/form4.xml","form_type":"4"}},{"id":913221,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":50705,"kind":"person","name":"FRIST THOMAS F III","position":1,"cik":"0001223892","reported_name":"FRIST THOMAS F III","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:29.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":false,"shares":36629188,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco Holding II (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-004684","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004684/form4.xml","form_type":"4"}},{"id":913220,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":67113,"kind":"person","name":"Elcan Patricia F","position":1,"cik":"0001433376","reported_name":"Elcan Patricia F","relationship":{"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:27.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":true,"shares":36557141,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of her pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,971,002 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee."}],"balance_after":36557141,"source":{"system":"sec-edgar","filing":"0001140361-26-004683","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004683/form4.xml","form_type":"4"}},{"id":913219,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":67113,"kind":"person","name":"Elcan Patricia F","position":1,"cik":"0001433376","reported_name":"Elcan Patricia F","relationship":{"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:27.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":false,"shares":36629188,"ownership":{"direct":false,"nature":"By Frisco Holding II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, Frisco (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, Frisco (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On February 6, 2026, Frisco (\"Frisco\") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-004683","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004683/form4.xml","form_type":"4"}},{"id":913218,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":67112,"kind":"person","name":"HERCULES HOLDING II","position":1,"cik":"0001392780","reported_name":"HERCULES HOLDING II","relationship":{"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:25.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":false,"shares":36629188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a distribution for no consideration and on a pro rata basis by the Reporting Person of 36,629,188 shares of Common Stock, par value $0.01 per share, of HCA Healthcare, Inc. to Frisco Holding II, which shares had previously been indirectly beneficially owned through the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a distribution for no consideration and on a pro rata basis by the Reporting Person of 36,629,188 shares of Common Stock, par value $0.01 per share, of HCA Healthcare, Inc. to Frisco Holding II, which shares had previously been indirectly beneficially owned through the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr."}],"balance_after":32282889,"source":{"system":"sec-edgar","filing":"0001140361-26-004682","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004682/form4.xml","form_type":"4"}},{"id":913216,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":67111,"kind":"person","name":"Frisco Holding II","position":1,"cik":"0001433317","reported_name":"Frisco Holding II","relationship":{"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:24.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":true,"shares":36557141,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, the Reporting Person disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to the Reporting Person, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of the Reporting Person to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, the Reporting Person disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to the Reporting Person, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of the Reporting Person to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."}],"balance_after":36557141,"source":{"system":"sec-edgar","filing":"0001140361-26-004681","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004681/form4.xml","form_type":"4"}},{"id":913215,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":67111,"kind":"person","name":"Frisco Holding II","position":1,"cik":"0001433317","reported_name":"Frisco Holding II","relationship":{"ten_percent_owner":true}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-02-10T20:05:24.000Z","date":"2026-02-06","kind":"other","planned":false,"acquired":false,"shares":36629188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 6, 2026, the Reporting Person disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to the Reporting Person, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of the Reporting Person to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 6, 2026, the Reporting Person disposed of 36,629,188 shares of Common Stock, par value $0.01 per share (\"Shares\"), of HCA Healthcare, Inc. (the \"Issuer\"), in exchange for 36,557,141 Shares newly issued by the Issuer to the Reporting Person, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of the Reporting Person to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Shares disposed of were previously reported by the Reporting Person as indirectly beneficially owned through Hercules Holding II (\"Hercules\"). Prior to the disposition reported in this filing, those shares were distributed for no consideration and on a pro rata basis by Hercules, effecting a change in form of beneficial ownership without changing the Reporting Person's pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-26-004681","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000114036126004681/form4.xml","form_type":"4"}},{"id":915139,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66801,"kind":"person","name":"Wyatt Christopher F.","position":1,"cik":"0001673365","reported_name":"Wyatt Christopher F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Appreciation Right","published_at":"2026-02-09T18:13:45.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":10670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020."}],"balance_after":0,"derivative":{"exercise_price":139.06,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":10670},"source":{"system":"sec-edgar","filing":"0001193125-26-043147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526043147/ownership.xml","form_type":"4"}},{"id":915138,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66801,"kind":"person","name":"Wyatt Christopher F.","position":1,"cik":"0001673365","reported_name":"Wyatt Christopher F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2026-02-09T18:13:45.000Z","date":"2026-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":5674,"price":513.76,"value":2915074.24,"ownership":{"direct":true},"balance_after":46063,"source":{"system":"sec-edgar","filing":"0001193125-26-043147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526043147/ownership.xml","form_type":"4"}},{"id":915137,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66801,"kind":"person","name":"Wyatt Christopher F.","position":1,"cik":"0001673365","reported_name":"Wyatt Christopher F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2026-02-09T18:13:45.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":10670,"price":139.06,"value":1483770.2,"ownership":{"direct":true},"balance_after":51737,"source":{"system":"sec-edgar","filing":"0001193125-26-043147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526043147/ownership.xml","form_type":"4"}},{"id":915135,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Stock Appreciation Right","published_at":"2026-02-09T18:08:02.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":29330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020."}],"balance_after":0,"derivative":{"exercise_price":139.06,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":29330},"source":{"system":"sec-edgar","filing":"0001193125-26-043139","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526043139/ownership.xml","form_type":"4"}},{"id":915134,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2026-02-09T18:08:02.000Z","date":"2026-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":16076,"price":513.76,"value":8259205.76,"ownership":{"direct":true},"balance_after":13254,"source":{"system":"sec-edgar","filing":"0001193125-26-043139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526043139/ownership.xml","form_type":"4"}},{"id":915133,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2026-02-09T18:08:02.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":29330,"price":139.06,"value":4078629.8,"ownership":{"direct":true},"balance_after":29330,"source":{"system":"sec-edgar","filing":"0001193125-26-043139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526043139/ownership.xml","form_type":"4"}},{"id":918370,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-04","kind":"other","planned":false,"acquired":true,"shares":1045,"price":498.35,"value":520775.75,"ownership":{"direct":false,"nature":"By HD Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Pursuant to a power of substitution, on February 4, 2026, the Reporting Person transferred 1,045 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $498.35 (the average of the high and low prices of shares of common stock of the Issuer on February 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":16024,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918369,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-04","kind":"other","planned":false,"acquired":false,"shares":1045,"price":498.35,"value":520775.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Pursuant to a power of substitution, on February 4, 2026, the Reporting Person transferred 1,045 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $498.35 (the average of the high and low prices of shares of common stock of the Issuer on February 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":31231,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918368,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":120,"price":497.1783,"value":59661.396,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.10 to $497.38, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":32276,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918367,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":4293,"price":498.123,"value":2138442.039,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.49 to $498.385, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":32396,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918366,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":5162,"price":498.7977,"value":2574793.7274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $498.41 to $499.395, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36689,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918365,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":6189,"price":500.0176,"value":3094608.9264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $499.47 to $500.425, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41851,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918364,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":7395,"price":500.6932,"value":3702626.214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $500.44 to $501.425, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48040,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918363,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":5002,"price":502.1505,"value":2511756.801,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.485 to $502.455, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":55435,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918362,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-05T18:33:00.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":14716,"price":502.9482,"value":7401385.7112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $502.49  to $503.485, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60437,"source":{"system":"sec-edgar","filing":"0001193125-26-039805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039805/ownership.xml","form_type":"4"}},{"id":918361,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2026-02-05T18:22:19.000Z","date":"2026-02-03","kind":"gift","planned":false,"acquired":false,"shares":4050,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25952.9017,"source":{"system":"sec-edgar","filing":"0001193125-26-039795","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039795/ownership.xml","form_type":"4"}},{"id":918360,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2026-02-05T18:22:19.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":498.0901,"value":747135.15,"ownership":{"direct":true},"balance_after":30002.9017,"source":{"system":"sec-edgar","filing":"0001193125-26-039795","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526039795/ownership.xml","form_type":"4"}},{"id":926061,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66801,"kind":"person","name":"Wyatt Christopher F.","position":1,"cik":"0001673365","reported_name":"Wyatt Christopher F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:50:59.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":2560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027."}],"balance_after":2560,"derivative":{"exercise_price":482.53,"exercise_date":"2027-01-29","expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":2560},"source":{"system":"sec-edgar","filing":"0001193125-26-034009","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034009/ownership.xml","form_type":"4"}},{"id":926060,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:50:16.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":8067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027."}],"balance_after":8067,"derivative":{"exercise_price":482.53,"exercise_date":"2027-01-29","expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":8067},"source":{"system":"sec-edgar","filing":"0001193125-26-034008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034008/ownership.xml","form_type":"4"}},{"id":926055,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:49:34.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":11945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027."}],"balance_after":11945,"derivative":{"exercise_price":482.53,"exercise_date":"2027-01-29","expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":11945},"source":{"system":"sec-edgar","filing":"0001193125-26-034007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034007/ownership.xml","form_type":"4"}},{"id":926059,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:49:00.000Z","date":"2026-01-30","kind":"exercise","planned":false,"acquired":false,"shares":84360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":81.96,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":84360},"source":{"system":"sec-edgar","filing":"0001193125-26-034005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034005/ownership.xml","form_type":"4"}},{"id":926058,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:49:00.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":55846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027."}],"balance_after":55846,"derivative":{"exercise_price":482.53,"exercise_date":"2027-01-29","expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":55846},"source":{"system":"sec-edgar","filing":"0001193125-26-034005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034005/ownership.xml","form_type":"4"}},{"id":926057,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T18:49:00.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":41483,"price":488.27,"value":20254904.41,"ownership":{"direct":true},"balance_after":75153,"source":{"system":"sec-edgar","filing":"0001193125-26-034005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034005/ownership.xml","form_type":"4"}},{"id":926056,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-02T18:49:00.000Z","date":"2026-01-30","kind":"exercise","planned":false,"acquired":true,"shares":84360,"price":81.96,"value":6914145.6,"ownership":{"direct":true},"balance_after":116636,"source":{"system":"sec-edgar","filing":"0001193125-26-034005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034005/ownership.xml","form_type":"4"}},{"id":926054,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:44:35.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":11945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027."}],"balance_after":11945,"derivative":{"exercise_price":482.53,"exercise_date":"2027-01-29","expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":11945},"source":{"system":"sec-edgar","filing":"0001193125-26-034000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526034000/ownership.xml","form_type":"4"}},{"id":926053,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:43:42.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":8067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027."}],"balance_after":8067,"derivative":{"exercise_price":482.53,"exercise_date":"2027-01-29","expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":8067},"source":{"system":"sec-edgar","filing":"0001193125-26-033998","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526033998/ownership.xml","form_type":"4"}},{"id":926051,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66798,"kind":"person","name":"Berres Jennifer","position":1,"cik":"0001793262","reported_name":"Berres Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Human Res. Officer"}}],"security":"Stock Appreciation Right","published_at":"2026-02-02T18:42:51.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":6206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027."}],"balance_after":6206,"derivative":{"exercise_price":482.53,"exercise_date":"2027-01-29","expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":6206},"source":{"system":"sec-edgar","filing":"0001193125-26-033997","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526033997/ownership.xml","form_type":"4"}},{"id":996929,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-18T18:23:04.000Z","date":"2025-11-14","kind":"gift","planned":false,"acquired":false,"shares":14830,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32276,"source":{"system":"sec-edgar","filing":"0001193125-25-286555","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525286555/ownership.xml","form_type":"4"}},{"id":1007420,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Stock Appreciation Right","published_at":"2025-11-05T18:15:33.000Z","date":"2025-11-03","kind":"exercise","planned":false,"acquired":false,"shares":13170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights vested in two equal annual installments beginning on January 28, 2023."}],"balance_after":0,"derivative":{"exercise_price":236.61,"expiration_date":"2032-01-28","underlying":"Common Stock","underlying_shares":13170},"source":{"system":"sec-edgar","filing":"0001193125-25-267409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525267409/ownership.xml","form_type":"4"}},{"id":1007419,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2025-11-05T18:15:33.000Z","date":"2025-11-05","kind":"sale","planned":false,"acquired":false,"shares":3892,"price":473.79,"value":1843990.68,"ownership":{"direct":true},"balance_after":3487,"source":{"system":"sec-edgar","filing":"0001193125-25-267409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525267409/ownership.xml","form_type":"4"}},{"id":1007418,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2025-11-05T18:15:33.000Z","date":"2025-11-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":9278,"price":461.56,"value":4282353.68,"ownership":{"direct":true},"balance_after":7379,"source":{"system":"sec-edgar","filing":"0001193125-25-267409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525267409/ownership.xml","form_type":"4"}},{"id":1007417,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":18874,"kind":"person","name":"McAlevey Michael R","position":1,"cik":"0001907875","reported_name":"McAlevey Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal & Admin Off."}}],"security":"Common Stock","published_at":"2025-11-05T18:15:33.000Z","date":"2025-11-03","kind":"exercise","planned":false,"acquired":true,"shares":13170,"price":236.61,"value":3116153.7,"ownership":{"direct":true},"balance_after":16657,"source":{"system":"sec-edgar","filing":"0001193125-25-267409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525267409/ownership.xml","form_type":"4"}},{"id":1007410,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-11-05T18:13:11.000Z","date":"2025-11-05","kind":"gift","planned":false,"acquired":false,"shares":165,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-267406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525267406/ownership.xml","form_type":"4"}},{"id":1007409,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-11-05T18:13:11.000Z","date":"2025-11-03","kind":"gift","planned":false,"acquired":true,"shares":165,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":165,"source":{"system":"sec-edgar","filing":"0001193125-25-267406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525267406/ownership.xml","form_type":"4"}},{"id":1007408,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-11-05T18:13:11.000Z","date":"2025-11-03","kind":"gift","planned":false,"acquired":false,"shares":165,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By MAM 2020 Trust"},"balance_after":43240,"source":{"system":"sec-edgar","filing":"0001193125-25-267406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525267406/ownership.xml","form_type":"4"}},{"id":1008907,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Appreciation Right","published_at":"2025-11-04T18:16:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":58050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017."}],"balance_after":0,"derivative":{"exercise_price":69.58,"expiration_date":"2026-01-29","underlying":"Common Stock","underlying_shares":58050},"source":{"system":"sec-edgar","filing":"0001193125-25-265148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525265148/ownership.xml","form_type":"4"}},{"id":1008906,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-04T18:16:35.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":28173,"price":459.68,"value":12950564.64,"ownership":{"direct":true},"balance_after":47106,"source":{"system":"sec-edgar","filing":"0001193125-25-265148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525265148/ownership.xml","form_type":"4"}},{"id":1008905,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-04T18:16:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":58050,"price":69.58,"value":4039119.0,"ownership":{"direct":true},"balance_after":75279,"source":{"system":"sec-edgar","filing":"0001193125-25-265148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525265148/ownership.xml","form_type":"4"}},{"id":1046413,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Stock Appreciation Right","published_at":"2025-09-08T18:37:12.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":false,"shares":10920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022."}],"balance_after":10000,"derivative":{"exercise_price":173.12,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":10920},"source":{"system":"sec-edgar","filing":"0001632835-25-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000163283525000003/ownership.xml","form_type":"4"}},{"id":1046412,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2025-09-08T18:37:12.000Z","date":"2025-09-08","kind":"sale","planned":true,"acquired":false,"shares":3836,"price":418.84,"value":1606670.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans."}],"balance_after":31502.9017,"source":{"system":"sec-edgar","filing":"0001632835-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000163283525000003/ownership.xml","form_type":"4"}},{"id":1046411,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2025-09-08T18:37:12.000Z","date":"2025-09-04","kind":"tax_withholding","planned":true,"acquired":false,"shares":7084,"price":411.59,"value":2915703.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans."}],"balance_after":35338.9017,"source":{"system":"sec-edgar","filing":"0001632835-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000163283525000003/ownership.xml","form_type":"4"}},{"id":1046410,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66796,"kind":"person","name":"Cuffe Michael S.","position":1,"cik":"0001632835","reported_name":"Cuffe Michael S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2025-09-08T18:37:12.000Z","date":"2025-09-04","kind":"exercise","planned":true,"acquired":true,"shares":10920,"price":173.12,"value":1890470.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans."}],"balance_after":42422.9017,"source":{"system":"sec-edgar","filing":"0001632835-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000163283525000003/ownership.xml","form_type":"4"}},{"id":1078698,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":44326,"kind":"person","name":"CHIDSEY JOHN","position":1,"cik":"0001128484","reported_name":"CHIDSEY JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-31T18:37:12.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common stock underlying 496 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date."}],"balance_after":496,"source":{"system":"sec-edgar","filing":"0000950170-25-101052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025101052/ownership.xml","form_type":"4"}},{"id":1148228,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-15T17:56:49.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":true,"shares":90076,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By 2023 Trust"},"balance_after":93088,"source":{"system":"sec-edgar","filing":"0000950170-25-072916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072916/ownership.xml","form_type":"4"}},{"id":1148227,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66797,"kind":"person","name":"HAZEN SAMUEL N","position":1,"cik":"0001216838","reported_name":"HAZEN SAMUEL N","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-15T17:56:49.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":false,"shares":90076,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By 2022 GRAT"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-072916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072916/ownership.xml","form_type":"4"}},{"id":1148226,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2025-05-15T17:54:39.000Z","date":"2025-05-13","kind":"other","planned":false,"acquired":true,"shares":15925,"price":367.195,"value":5847580.375,"ownership":{"direct":false,"nature":"By LCF Trust (Reporting Person, Trustee)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a power of substitution, on May 13, 2025, the Reporting Person's spouse transferred 15,925 shares of common stock of the Issuer to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $367.195 (the average of the high and low prices of shares of common stock of the Issuer on May 13, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":72308,"source":{"system":"sec-edgar","filing":"0000950170-25-072914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072914/ownership.xml","form_type":"4"}},{"id":1148225,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2025-05-15T17:54:39.000Z","date":"2025-05-13","kind":"other","planned":false,"acquired":false,"shares":15925,"price":367.195,"value":5847580.375,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a power of substitution, on May 13, 2025, the Reporting Person's spouse transferred 15,925 shares of common stock of the Issuer to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $367.195 (the average of the high and low prices of shares of common stock of the Issuer on May 13, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-072914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072914/ownership.xml","form_type":"4"}},{"id":1148224,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2025-05-15T17:54:39.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LCF Trust (Reporting Person, Trustee)"},"balance_after":56383,"source":{"system":"sec-edgar","filing":"0000950170-25-072914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072914/ownership.xml","form_type":"4"}},{"id":1148223,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2025-05-15T17:54:39.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":false,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":15925,"source":{"system":"sec-edgar","filing":"0000950170-25-072914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072914/ownership.xml","form_type":"4"}},{"id":1148222,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2025-05-15T17:54:39.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":true,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By JMF Trust (Spouse and Robert Nagel, Co-Trustees)"},"balance_after":67595,"source":{"system":"sec-edgar","filing":"0000950170-25-072914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072914/ownership.xml","form_type":"4"}},{"id":1148221,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2025-05-15T17:54:39.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":false,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11566,"source":{"system":"sec-edgar","filing":"0000950170-25-072914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072914/ownership.xml","form_type":"4"}},{"id":1148220,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":66799,"kind":"person","name":"Foster Jon M","position":1,"cik":"0001513235","reported_name":"Foster Jon M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and COO"}}],"security":"Common Stock","published_at":"2025-05-15T17:54:39.000Z","date":"2025-05-13","kind":"sale","planned":false,"acquired":false,"shares":15698,"price":369.3248,"value":5797660.7104,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.80 to $370.56, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12646,"source":{"system":"sec-edgar","filing":"0000950170-25-072914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025072914/ownership.xml","form_type":"4"}},{"id":1155568,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-05-08T18:40:51.000Z","date":"2025-05-07","kind":"gift","planned":false,"acquired":false,"shares":144,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-067306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025067306/ownership.xml","form_type":"4"}},{"id":1155567,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-05-08T18:40:51.000Z","date":"2025-05-07","kind":"other","planned":false,"acquired":true,"shares":285,"price":356.84,"value":101699.4,"ownership":{"direct":false,"nature":"By MAM 2020 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a power of substitution, on May 7, 2025, the Reporting Person transferred 285 shares of common stock of the Issuer and cash to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $356.84 (the average of the high and low prices of shares of common stock of the Issuer on May 7, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":43405,"source":{"system":"sec-edgar","filing":"0000950170-25-067306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025067306/ownership.xml","form_type":"4"}},{"id":1155566,"issuer":{"id":2929,"kind":"organization","name":"HCA Healthcare, Inc.","symbol":"HCA"},"owners":[{"id":48495,"kind":"person","name":"Marks Mike A","position":1,"cik":"0001961124","reported_name":"Marks Mike A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-05-08T18:40:51.000Z","date":"2025-05-07","kind":"other","planned":false,"acquired":false,"shares":285,"price":356.84,"value":101699.4,"ownership":{"direct":false,"nature":"By ML Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to a power of substitution, on May 7, 2025, the Reporting Person transferred 285 shares of common stock of the Issuer and cash to a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $356.84 (the average of the high and low prices of shares of common stock of the Issuer on May 7, 2025). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-067306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/860730/000095017025067306/ownership.xml","form_type":"4"}}],"next_cursor":"2025-05-08T18:40:51.000000Z,1155566"}